https://www.heartfailure-pathway.elicla-dev.be/en/news/the-first-multidisciplinary-care-pathway-for-heart-failure-for-belgium-is-here/2024-11-10T17:21:40+01:00https://www.heartfailure-pathway.elicla-dev.be/en/news/telemonitoring-for-patients-with-heart-failure-is-reimbursed-from-01-01-2025-in-belgium/2025-01-14T10:32:45+01:00https://www.heartfailure-pathway.elicla-dev.be/en/news/european-heart-failure-association-congress-2026/2025-07-09T15:48:42+02:00https://www.heartfailure-pathway.elicla-dev.be/en/news/new-treatment-for-cardiac-attr-amyloidosis-reimbursed-beyonttra/2026-01-23T09:36:28+01:00https://www.heartfailure-pathway.elicla-dev.be/en/news/article-in-world-health-leaders-in-december-2025-innovating-heart-failure-management-beyond-traditional-guidelines/2026-01-14T11:59:24+01:00https://www.heartfailure-pathway.elicla-dev.be/en/news/the-general-practitioner-can-now-also-extend-the-reimbursement-of-sglt-2-inhibitors-for-heart-failure-in-belgium/2026-03-27T14:25:45+01:00